The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Smirnova M.I.

National Medical Research Center for Therapy and Preventive Medicine

Antipushina D.N.

National Medical Research Center for Therapy and Preventive Medicine

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Changes in asthma treatment guidelines from 2019. Review of data to help primary care physician

Authors:

Smirnova M.I., Antipushina D.N., Drapkina O.M.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2021;24(5): 72‑80

DOI: 10.17116/profmed20212405172

Read: 33370 times

Download PDF (RU)
Contact the author
Table of contents

CHANGES IN ASTHMA TREATMENT GUIDELINES FROM 2019. REVIEW OF DATA TO HELP PRIMARY CARE PHYSICIAN
CHANGES IN ASTHMA TREATMENT GUIDELINES FROM 2019. REVIEW OF DATA TO HELP PRIMARY CARE PHYSICIAN

To cite this article:

Smirnova MI, Antipushina DN, Drapkina OM. Changes in asthma treatment guidelines from 2019. Review of data to help primary care physician. Russian Journal of Preventive Medicine. 2021;24(5):72‑80. (In Russ.)
https://doi.org/10.17116/profmed20212405172

Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Neutrophil elastase as a promising biomarker of low-grade inflammation in chro­nic non-communicable diseases. Russian Journal of Preventive Medi­cine. 2025;(4):142-148
Vaccination against pneumococcal infe­ction as a mean of redu­cing morbidity and mortality of the adult popu­lation from risk groups in the Russian Fede­ration. (Resolution of the Council of Expe­rts). Russian Journal of Preventive Medi­cine. 2025;(7):7-14
A Randomized Controlled Trial Comparing Bude­sonide and Mome­tasone Furoate Nasal Spray in the Treatment of Chro­nic Rhinosinusitis with Nasal Poly­posis: Evaluating Symptom Scores and Quality of Life. Russian Rhinology. 2025;(1):12-17
Immu­notherapy in the treatment of chro­nic poly­pous rhinosinusitis with como­rbid bronchial asthma. Russian Bulletin of Otorhinolaryngology. 2025;(1):29-34
Acce­ssibility of health and preventive care for patients with bronchial asthma. Journal of Respiratory Medi­cine. 2025;(1):15-22
Effi­cacy of dupi­lumab application in bullous pemphigoid proceeding in presence of bronchial asthma. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):204-209
Labo­ratory considerations in asse­ssing effi­cacy and safety of biologic therapy in the elde­rly (as Exemplified by Asthma). Labo­ratory Service. 2025;(2):29-32
Mono­clonal anti­bodies in the treatment of recu­rrent poly­posis rhinosinusitis. Lite­rature review. Russian Bulletin of Otorhinolaryngology. 2025;(4):96-104
Mechanisms of addi­tivity of physiotherapeutic factors in complex therapy of poly­pous rhinosinusitis complicated by como­rbidities. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(3):5-11
Influence of age and sex on values of SNOT-22 sino­nasal test domains in children and adolescents with bronchial asthma. Russian Rhinology. 2025;(3):197-204
Abstract:

Asthma is a common chronic respiratory disease. The risk of severe exacerbations of asthma exists for any severity of the disease, including mild asthma. This emphasizes the importance of the correct application of clinical guidelines by primary care physicians in routine practice. This article provides a brief overview of updates in the international document GINA 2019 and 2020, and the unscheduled recommendations of the Russian Respiratory Society in 2019, and their reasons. The article focuses on those key changes that need to be considered in the routine work of a general practitioner in the management of an asthma patient.

Keywords:

β2-agonist
asthma
budesonide
rapid-acting bronchodilator
inhaled glucocorticosteroid
short-acting bronchodilator
asthma therapy
anti-inflammatory bronchodilator
recommendations
single inhaler regimen
salbutamol
formoterol

Authors:

Smirnova M.I.

National Medical Research Center for Therapy and Preventive Medicine

Antipushina D.N.

National Medical Research Center for Therapy and Preventive Medicine

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Received:

16.03.2021

Accepted:

25.03.2021

Close metadata

References:

  1. Mukherjee M, Stoddart A, Gupta RP, Nwaru BI, Farr A, Heaven M, Fitzsimmons D, Bandyopadhyay A, Aftab C, Simpson CR, Lyons RA, Fischbacher C, Dibben C, Shields MD, Phillips CJ, Strachan DP, Davies GA, McKinstry B, Sheikh A.The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases. BMC Med. 2016;14:113.  https://doi.org/10.1186/s12916-016-0657-8
  2. Ebmeier S, Thayabaran D, Braithwaite I, Bénamara C, Weatherall M, Beasley R. Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries. Lancet. 2017;390:935-945.  https://doi.org/10.1016/S0140-6736(17)31448-4
  3. Dusser D, Montani D, Chanez P, de Blic J, Delacourt C, Deschildre A, Devillier P, Didier A, Leroyer C, Marguet C, Martinat Y, Piquet J, Raherison C, Serrier P, Tillie-Leblond I, Tonnel AB, Tunon de Lara M, Humbert M. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy. 2007;62(6):591-604.  https://doi.org/10.1111/j.1398-9995.2007.01394.x
  4. Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J. 2008;31:320-325.  https://doi.org/10.1183/09031936.00039707
  5. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.  https://doi.org/10.1186/1471-2466-6-13
  6. FitzGerald JM, Boulet LP, McIvor RA, Zimmerman S, Chapman KR. Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J. 2006;13:253-259.  https://doi.org/10.1155/2006/753083
  7. Arkhipov VV, Grigoryeva EV, Gavrishina EV. Control of bronchial asthma in Russia: results of NIKA multi-center observational study. Pulmonologi. 2011;6:87-93. (In Russ.). https://doi.org/10.18093/0869-0189-2011-0-6-87-93
  8. Canonica GW, Baena-Cagnani CE, Blaiss MS, Dahl R, Kaliner MA, Valovirta EJ. GAPP Survey Working Group. Unmet needs in asthma: Global Asthma Physician and Patient (GAPP) Survey: global adult findings. Allergy. 2007;62(6):668-674.  https://doi.org/10.1111/j.1398-9995.2007.01352.x
  9. Levy ML. National Review of Asthma Deaths (NRAD). British Journal of General Practice. 2014;64(628):564.  https://doi.org/10.3399/bjgp14x682237
  10. Gupta S, Rai N, Bhattacharrya O, Cheng AYY, Connelly KA, Boulet LP, Kaplan A, Brouwers MC, Kastner M. Optimizing the language and format of guidelines to improve guideline uptake. CMAJ. 2016;188:362-368.  https://doi.org/10.1503/cmaj.151102
  11. Price D, Fletcher M, van der MolenT. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009. https://doi.org/10.1038/npjpcrm.2014.9
  12. O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK. Inhaled combined budesonide-formoterol as needed in mild asthma. The New England Journal of Medicine. 2018;378(20):1865-1876. https://doi.org/10.1056/nejmoa1715274
  13. Beasley R, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Houghton C, Oldfield K, Papi A, Pavord ID, Williams M, Weatherall M. Novel START Study Team. Controlled trial of budesonide-formoterol as needed for mild asthma. The New England Journal of Medicine. 2019;380(21):2020-2030. https://doi.org/10.1056/nejmoa1901963
  14. Bateman ED, Reddel HK, O’Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. The New England Journal of Medicine. 2018;378(20):1877-1887. https://doi.org/10.1056/nejmoa1715275
  15. Stanford RH, Shah MB, D’Souza AO, Dhamane AD, Schatz M. Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Ann Allergy Asthma Immunol. 2012;109:403-407.  https://doi.org/10.1016/j.anai.2012.08.014
  16. Freedman T. Medihaler therapy for bronchial asthma; a new type of aerosol therapy. Postgrad Med. 1956;20(6):667-673.  https://doi.org/10.1080/00325481.1956.11691366
  17. Rubin BK, Fink JB. Optimizing aerosol delivery by pressurized metered-dose inhalers. Respir Care. 2005;50(9):1191-1200.
  18. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000; 343:332-336.  https://doi.org/10.1056/NEJM200008033430504
  19. Swystun VA, Gordon JR, Davis EB, Zhang X, Cockcroft DW. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. Clinical Trial J Allergy Clin Immunol. 2000;106(1):57-64.  https://doi.org/10.1067/mai.2000.107396
  20. British Guideline on the management of Asthma. Quick Reference Guide. London: British Thoracic Society; 2016. Accessed March 30, 2021. https://www.brit-thoracic.org.uk/document-library/guidelines/asthma/btssign-asthma-guideline-quick-reference-guide-2016
  21. Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55:1901872. https://doi.org/10.1183/13993003.01872-2019
  22. Ringbaek T, Viskum K. Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma? Respir Med. 2003; 97(3):264-272.  https://doi.org/10.1053/rmed.2003.1423
  23. Grant IW. Fenoterol and asthma deaths. Thorax. 1998;53(1):77.  https://doi.org/10.1136/thx.53.1.77b
  24. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992;326(8):501-506.  https://doi.org/10.1056/NEJM199202203260801
  25. Lanes SF, García Rodríguez LA, Huerta C. Respiratory medications and risk of asthma death. Thorax. 2002;57:683-686.  https://doi.org/10.1136/thorax.57.8.683
  26. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. USA: GINA; 2019. Accessed March 15, 2021. https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf
  27. Klinicheskie rekomendacii «Bronhial’naya astma». Moskva: Ministerstvo Zdravoohraneniya Rossijskoj Federacii; 2019. Accessed March 12, 2021. (In Russ.). https://spulmo.ru/upload/kr_bronhastma_2019.pdf
  28. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. USA: GINA; 2006. Accessed March 15, 2021. https://www.who.int/respiratory/asthma/GINA_WR_2006_copyright%5B1%5D.pdf
  29. Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin. 2004;20(9):1403-1418. https://doi.org/10.1185/030079904X2051
  30. O’Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekström T, Bateman ED. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171(2):129-136.  https://doi.org/10.1164/rccm.200407-884OC
  31. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006; 368(9537):744-753.  https://doi.org/10.1016/S0140-6736(06)69284-2
  32. Rabe KF, Pizzichini E, Ställberg B, Romero S, Balanzat AM, Atienza T, Lier PA, Jorup C. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest. 2006;129(2):246-256.  https://doi.org/10.1378/chest.129.2.246
  33. Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med. 2007;101(12):2437-2446. https://doi.org/10.1016/j.rmed.2007.07.014
  34. Kuna P, Peters MJ, Manjra AI, Jorup C, Naya IP, Martínez-Jimenez NE, Buhl R. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract. 2007;61(5):725-736.  https://doi.org/10.1111/j.1742-1241.2007.01338.x
  35. Ogorodova LM, Petrovskij FI, Petrovskaya YuA. Klinicheskaya farmakologiya bronkhial`noj astmy`. Pod red. Chuchalina A.G. M.: Izdatel`stvo Atmosfera; 2002. (In Russ.).
  36. McLean S, Chandler D, Nurmatov U, Liu J, Pagliari C, Car J, Sheikh A. Telehealthcare for asthma: a Cochrane review. CMAJ. 2011;183(11):733-742.  https://doi.org/10.1503/cmaj.101146
  37. Smirnova MI, Antipushina DN, Drapkina OM. Distancionnye tekhnologii vedeniya bol’nyh bronhial’noj astmoj (obzor dannyh nauchnoj literatury). Profilakticheskaya medicina. 2019;22(6):125-132. (In Russ.). https://doi.org/10.17116//profmed201922061125
  38. Antipushina DN, Smirnova MI. Perspektivy distancionnogo kontrolya hronicheskoj obstruktivnoj bolezni legkih i bronhial’noj astmy. V sbornike: Fizika i radioelektronika v medicine i ekologii — FREME’2020. Trudy XIV Mezhdunarodnoj nauchnoj konferencii s nauchnoj molodezhnoj shkoloj im. I.N. Spiridonova. M.: FREME’2020; 2020. (In Russ.).
  39. Global Initiative for asthma (GINA. COVID-19: GINA answers to frequently asked questions on asthma management. USA: GINA; 2020. Accessed 30.03.2021. https://ginasthma.org/covid-19-gina-answers-to-frequently-asked-questions-on-asthma-management/
  40. Global Initiative for asthma (GINA). Global strategy for asthma management and prevention, updated 2020. USA: GINA; 2020. Accessed March 15, 2021. https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf
  41. Global Initiative for asthma (GINA). GINA: interim guidance about COVID-19 and asthma. USA: GINA; 2020. Accessed March 15, 2021. https://ginasthma.org/wp-content/uploads/2020/12/GINA-interim-guidance-on-COVID-19-and-asthma-20_12_20.pdf
  42. Hronicheskie bolezni legkih i COVID-19. Moskva: Rossijskoe respiratornoe obshchestvo; 2021. Accessed March 15, 2021. (In Russ.). https://spulmo.ru/covid-19/
  43. Smirnova MI, Antipushina DN, Kurekhyan AS. Bronhial’naya astma i allergicheskij rinit v epohu COVID-19: dannye publikacij pervoj vesny i rekomendacii ekspertov. Profilakticheskaya medicina. 2021;4:105-112.  https://doi.org/10.17116/profmed202124041105
  44. Hard J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R, PRACTICAL study team. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet. 2019;394(10202):919-928.  https://doi.org/10.1016/S0140-6736(19)31948-8
  45. Avdeev SN, Ajsanov ZR, Belevskij AS, Emel’yanov AV, Kurbacheva OM, Leshchenko IV, Nenasheva NM, Fassahov RS. Puti uluchsheniya diagnostiki i lecheniya bol’nyh bronhial’noj astmoj vrachami pervichnogo zvena. Pul’monologiya. 2019;29(4):457-467. (In Russ.). https://doi.org/10.18093/0869-0189-2019-29-4-457-467
  46. Federal’nyj zakon ot 21.11.11 No. 323-FZ (red. ot 31.07.20) «Ob osnovah ohrany zdorov’ya grazhdan v Rossijskoj Federacii». Accessed March 15, 2021. (In Russ.). https://www.consultant.ru/document/cons_doc_LAW_121895/
  47. Prikaz Minzdrava Rossii ot 10.05.17 No. 203n «Ob utverzhdenii kriteriev ocenki kachestva medicinskoj pomoshchi». (In Russ.). Accessed March 15, 2021. https://www.rncrr.ru/upload/Doc/N203.pdf
  48. Prikaz FFOMS ot 28.02.19 No. 36 «Ob utverzhdenii Poryadka organizacii i provedeniya kontrolya ob’emov, srokov, kachestva i usloviǐ predostavleniya medicinskoj pomoshchi po obyazatel’nomu medicinskomu strahovaniyu». Accessed March 15, 2021. (In Russ.). https://base.garant.ru/72271640/
  49. Prikaz Minzdravsocrazvitiya Rossii ot 15.05.12 No. 543n. «Ob utverzhdenii Polozheniya ob organizacii okazaniya pervichnoj mediko-sanitarnoj pomoshchi vzroslomu naseleniyu». Accessed March 15, 2021. (In Russ.). https://base.garant.ru/70195856/
  50. Prikaz Minzdrava Rossii ot 15.11.12 No. 916n «Ob utverzhdenii Poryadka okazaniya medicinskoj pomoshchi naseleniyu po profilyu «pul’monologiya». Accessed March 15, 2021. (In Russ.). https://minzdrav.gov.ru/documents/9136-prikaz-ministerstva-dravoohraneniya-rossiyskoy-federatsii-ot-15-noyabrya-2012-g-916n-ob-utverzhdenii-poryadka-okazaniya-editsinskoy-pomoschi-naseleniyu-po-profilyu-pulmonologiya
  51. Avdeev SN, Belevskij AS, Ajsanov ZR. Novye podhody i algoritm vedeniya pacientov s bronhial’noj astmoj. Prakticheskaya pul’monologiya. 2019;1:44-46. Accessed March 15, 2021. (In Russ.). https://cyberleninka.ru/article/n/novye-podhody-i-algoritm-vedeniya-patsientov-s-bronhialnoy-astmoy
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.